Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.96
(
-1.06%
)
Bitcoin
75,818.94
(
-0.03%
)
News Focus
News Focus
Post# of 16
Public Reply Private Reply New Post
Keep Last Read
Keep Report Keyboard Shortcuts
Prev Next

whytestocks

Send PM Follow Ignore
Followers 131
Posts 15004
Boards Moderated 0
Alias Born 06/04/2018

whytestocks

Re: None

Monday, 10/19/2020 11:15:23 PM

Monday, October 19, 2020 11:15:23 PM

Post# of 16
NEWS: $MREO Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)

On track to initiate Phase 1b/2 basket study of etigilimab in combination with an anti-PD-1 in a series of tumor types in Q4 2020 Plans to host virtual R&D day to review etigilimab development program and rare disease product pipeline in November 2020 LONDON and REDWOOD CITY, ...

Find out more MREO - Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Report Keyboard Shortcuts
Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today